Hyderabad-based Biological E Limited will infuse an additional Rs 250 crore into its recently-commissioned biopharmaceutical and vaccine manufacturing campus over the next three years.
The 75-acre campus, located in phase-II of SP Biotech Park at Shameerpet on the outskirts of Hyderabad, was set up at an investment of over Rs 300 crore. The facility will manufacture vaccines and biopharmaceuticals that are crucial in the global effort to prevent childhood diseases. These products are intended for supply to markets worldwide, including the US and Europe, through the company's strategic partners.
“We expect to further invest in the new campus in the next two to three years in expanding capacities and creating infrastructure for the future pipeline of products,” the company stated in a press release on Monday.
Biological E, established in 1953, manufactures a range of biologics and vaccines including tetanus (TT), diphtheria-tetanus-pertussis (DTwP), hepatitis B and haemophilus influenza type B.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app